Concepedia

Nanda Kishore Routhu

NK

Statistics

Publications

8

Citations

356

H-Index

8

Active since

2018

Affiliations

Emory University(Current)

Ragon Institute of MGH, MIT and Harvard

University of Nebraska Medical Center

Atlanta VA Medical Center

University of North Carolina at Chapel Hill

Nanda Kishore Routhu is an author at Emory University specializing in infectious diseases, molecular virology, and viral vaccines.

ORCID

Publications per year

2018–2023

8

Publications

8

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata S. Bollimpelli et al. · Nature Communications · 2021 · 97 citations · Full text

, , +17

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Nanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara et al. · Immunity · 2021 · 91 citations · Full text

, , +14

Glycosylation of Zika Virus is Important in Host–Virus Interaction and Pathogenic Potential

Nanda Kishore Routhu, Sylvain Lehoux, Emily A. Rouse et al. · International Journal of Molecular Sciences · 2019 · 53 citations · Full text

, , +17

A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection

Nanda Kishore Routhu, Sailaja Gangadhara, Lilin Lai et al. · Science Immunology · 2022 · 50 citations · Full text

, , +17

Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates

Nanda Kishore Routhu, Samuel D. Stampfer, Lilin Lai et al. · Science Immunology · 2023 · 30 citations · Full text

, , +17

1–5 of 8